Organoid-based modeling of platinum resistance identifies KRT17 as both a response mediator and biomarker for targeted therapy in ovarian cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Radiology, Nuclear Medicine An...Radiology, Nuclear Medicine And ImagingNeuroscienceNeuroscienceCancer OncologyCancer OncologyBiomarkerBiomarkerBiologyBiology

Show all topics

DOI

10.1101/2025.03.10.642373

License

cc-by-nd

Other Formats

PDF